Intrinsic Value of S&P & Nasdaq Contact Us

Perrigo Company plc PRGO NYSE

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • IE • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
$20.94
+82.6%
Analyst Price Target
$21.50
+87.4%

Perrigo Company plc (PRGO) — Analyst outlook / Analyst consensus target is. Based on 36 analyst ratings, the consensus is bullish — 14 Buy, 21 Hold, 1 Sell.

The consensus price target is $21.50 (low: $20.00, high: $23.00), representing an upside of 87.4% from the current price $11.47.

Analysts estimate Earnings Per Share (EPS) of $2.56 and revenue of $4.43B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.25 vs est $2.56 (missed -148.8%). 2025: actual $-10.29 vs est $2.77 (missed -471.2%). Analyst accuracy: 0%.

PRGO Stock — 12-Month Price Forecast

$21.50
▲ +87.45% Upside
Average Price Target
Based on 36 Wall Street analysts offering 12-month price targets for Perrigo Company plc, the average price target is $21.50, with a high forecast of $23.00, and a low forecast of $20.00.
The average price target represents a +87.45% change from the last price of $11.47.
Highest Price Target
$23.00
Average Price Target
$21.50
Lowest Price Target
$20.00

PRGO Analyst Ratings

Hold
36
Ratings
14 Buy
21 Hold
1 Sell
Based on 36 analysts giving stock ratings to Perrigo Company plc in the past 3 months
Rating breakdown
Buy
14 39%
Hold
21 58%
Sell
1 3%
39%
Buy
14 analysts
58%
Hold
21 analysts
3%
Sell
1 analysts

EPS Estimates — PRGO

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$1.25 vs Est $2.56 ▼ 304.8% off
2025 Actual –$10.29 vs Est $2.77 ▼ 126.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.

Revenue Estimates — PRGO

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $4.373B vs Est $4.430B ▼ 1.3% off
2025 Actual $4.253B vs Est $4.246B ▲ 0.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message